The expression of hypoxia inducible factor 1-alpha in lung cancer and its correlation with P53 and VEGF

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 24, Issue 2, 2004, Pages 124-127

  Zhang, Huilan ^a   Zhang, Zhenxiang ^a   Xu, Yongjian ^a   Xing, Lihua ^a   Liu, Jianbo ^a   Li, Jun ^b   Tan, Qing ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Department of Surgery   (China)

^c Huachen Jinbei Auto Manufacture Co Ltd   (China)

Author keywords

Hypoxia inducible factor 1alpha; Lung cancer; P53; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL ORGANS; GROWTH KINETICS; HISTOLOGY; IMMUNOLOGY; PULMONARY DISEASES; TUMORS;

HYPOXIA INDUCIBLE FACTOR 1-ALPHA; LUNG CANCER; P53; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

PROTEINS;

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; VASCULOTROPIN A;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; FEMALE; GENETICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27644439866     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. 2 tension. Proc Natl Acad Sci USA, 1995,92(12):5510
2. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA, 1998,95(14):7987
3. Maxwell P, Salnikow K. HIF-1: An Oxygen and Metal Responsive Transcription Factor. Cancer Biol Ther, 2004,3:1
4. Giatromanolaki A, Koukourakis MI, Sivridis E et al. Relation of hypoxia inducible factor la and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer, 2001, 85 (6):881
5. Dykins R, Corbett I P, Henry J A et al. Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemistry study using monoclonal antibody NCL-CB11. J Pathol, 1991,163(2):105
6. Zhong H, De Marzo A M, Laughner E et al. Overex-pression of hypoxia inducible factor lalpha in common human cancers and their metastases. Cancer Res, 1999,59(22):5830
7. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev, 1997,18(1): 4
8. Forsythe J A, Jiang B H, Iyer N V et al. Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1. Mol Cell Biol, 1996,16(9):4604
9. Ryan HE, Lo J, Johnson RS. HIF-alpha is required for solid tumor formation and embryonic vascularization. Embo J, 1998,17(11):3005
10. Giaccia A J, Kastan M B. The complexity of P53 modulation: Emerging patterns from divergent signals. Genes Dev, 1998,12:2973
11. Graeber T G, Osmanian C, Jacks T et al. Hypoxis-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature, 1996,379(6560): 88
12. Haupt Y, Maya R, Kazaz A et al. Mdm2 promotes the rapid degradation of P53. Nature, 1997,387(6630): 266
13. Kubbutat M H G, Jones S N, Vousden K H. Regulation of P53 stability by Mdm2. Nature, 1997, 387(6630):299
14. Ravi R, Mookerjee B, Bhujwalla Z M et al. Regulation of tumor angiogenesis by P53-induced degradation of hypoxia inducible factorlα. Genes Dev, 2000,14(1): 34